Search Results 191-200 of 17100 for Cannabis

  1. Publications - Jillian A. Maloney, M.D. - Mayo Clinic

    Cannabis for the Treatment of Fibromyalgia: A Systematic Review. Biomedicines. 2023 Jun 2; 11 (6) Epub 2023 June 02. View PubMed; Keim AA, Pelkey MN ...

  2. Flibanserin (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...

  3. Ethchlorvynol (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Cetirizine; Chlordiazepoxide; Chlorzoxazone; Clobazam; Clomipramine; Clonazepam; Clorazepate ...

  4. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

    cannabis/tobacco smoke and nicotine vapors) or individuals who have given up smoking within the past 6 months, or those with >20 pack-year smoking history

  5. Priapism - Symptoms & causes - Mayo Clinic

    Ischemic priapism · Erection lasting more than four hours or unrelated to sexual interest or stimulation · Rigid penile shaft, but the tip of penis (glans) is ...

  6. Study to Assess the Effectiveness and Safety of Bradanicline in Patients with Chronic Cough - Mayo Clinic

    ... cannabis dependence or abuse. Active hepatitis infection. History of human immunodeficiency virus (HIV) infection. History of hypersensitivity to ...

  7. Carbinoxamine (oral route) - Side effects & dosage - Mayo Clinic

    Cannabis; Carbamazepine; Carbidopa; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone; Clobazam ...

  8. CardiolRx In Recurrent Pericarditis Following IL-1 Blocker Cessation - Mayo Clinic

    ... cannabis products for the duration of the trial 15. Pregnant or breastfeeding 16. Current diagnosis of active cancer, with the exception of non-melanoma ...

  9. A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression - Mayo Clinic

    Patients who meet DSM-IV-TR criteria for any significant current substance use disorder other than nicotine, caffeine, or cannabis. Must have at least early ...

  10. A Phase 3, Placebo-Controlled Study To Investigate LP352 In Children And Adults With Dravet Syndrome (DS) - Mayo Clinic

    * The participant has used any cannabis product or cannabidiol that is not in oral solution/capsule/tablet form, not obtained from a government-approved ...